Source: published Phase 2 and Phase 3 trial data (cross-study, not head-to-head)
Novo Nordisk: The underdog is making a comeback Novo Nordisk was first to market with a GLP-1 shot and also first with a GLP-1 pill
Helps with chronic bronchitis
Where most GLP-1 strategies fall short GLP-1s can help people lose weight and control blood sugar, but medication alone isnt enough to deliver lasting clinical and financial results
Social media frequently distorts realistic expectations by highlighting extreme hyper-responders who claim immediate, massive weight drops within days
Our top pick is BPC-157, thanks to its uniquely broad research base spanning tendon, muscle, and gut repair alongside a favorable short-term tolerability profile in the available human data, while Collagen Peptides earns the budget and accessibility nod as the only non-injectable, over-the-counter option on this list, backed by randomized trials on skin hydration and joint comfort